Credit Suisse’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$6.7M Buy
903,257
+6,781
+0.8% +$50.3K 0.01% 1134
2023
Q4
$9.08M Sell
896,476
-245,865
-22% -$2.49M 0.01% 966
2023
Q3
$8.91M Buy
1,142,341
+68,661
+6% +$536K 0.01% 944
2023
Q2
$8.84M Buy
1,073,680
+95,717
+10% +$788K 0.01% 968
2023
Q1
$7.09M Sell
977,963
-5,795
-0.6% -$42K 0.01% 1086
2022
Q4
$8.73M Sell
983,758
-16,620
-2% -$147K 0.01% 977
2022
Q3
$12.2M Sell
1,000,378
-50,195
-5% -$614K 0.01% 812
2022
Q2
$12.4M Sell
1,050,573
-26,573
-2% -$314K 0.01% 848
2022
Q1
$20.5M Buy
1,077,146
+6,276
+0.6% +$119K 0.02% 749
2021
Q4
$28.4M Sell
1,070,870
-4,494
-0.4% -$119K 0.02% 670
2021
Q3
$44.2M Buy
1,075,364
+42,024
+4% +$1.73M 0.02% 506
2021
Q2
$58.5M Buy
1,033,340
+131,137
+15% +$7.43M 0.03% 442
2021
Q1
$37.9M Buy
902,203
+54,224
+6% +$2.28M 0.02% 613
2020
Q4
$59.5M Sell
847,979
-124,571
-13% -$8.73M 0.03% 445
2020
Q3
$27.3M Sell
972,550
-45,033
-4% -$1.26M 0.02% 634
2020
Q2
$30.1M Buy
1,017,583
+27,689
+3% +$819K 0.02% 587
2020
Q1
$19.6M Buy
989,894
+19,642
+2% +$389K 0.02% 679
2019
Q4
$28.7M Buy
970,252
+14,414
+2% +$427K 0.02% 627
2019
Q3
$21.7M Sell
955,838
-32,407
-3% -$737K 0.02% 658
2019
Q2
$24.5M Buy
988,245
+32,517
+3% +$804K 0.02% 624
2019
Q1
$23.4M Sell
955,728
-7,522
-0.8% -$184K 0.02% 612
2018
Q4
$21.9M Buy
963,250
+180,162
+23% +$4.1M 0.02% 613
2018
Q3
$24.9M Buy
783,088
+227,266
+41% +$7.23M 0.02% 636
2018
Q2
$19.9M Sell
555,822
-96,260
-15% -$3.45M 0.02% 699
2018
Q1
$21.6M Buy
652,082
+276,794
+74% +$9.18M 0.02% 694
2017
Q4
$11.5M Buy
375,288
+253,627
+208% +$7.79M 0.01% 954
2017
Q3
$2.92M Sell
121,661
-65,922
-35% -$1.58M ﹤0.01% 1845
2017
Q2
$3.15M Buy
187,583
+33,570
+22% +$563K ﹤0.01% 1619
2017
Q1
$3.44M Sell
154,013
-72,168
-32% -$1.61M ﹤0.01% 1649
2016
Q4
$3.67M Buy
226,181
+140,849
+165% +$2.29M ﹤0.01% 1639
2016
Q3
$1.15M Buy
+85,332
New +$1.15M ﹤0.01% 2525